John Alexander

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Top Venues

British journal of cancer

Cancer research

Nature communications

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

John Alexander, Koen Schipper, Sarah Nash, Rachel Brough, Harriet Kemp, Jacopo Iacovacci, Clare M Isacke, Rachael Natrajan, Elinor J Sawyer, Christopher J Lord, Syed Haider
Pathway-based signatures predict patient outcome, chemotherapy benefit and synthetic lethal dependencies in invasive lobular breast cancer. British journal of cancer 130 (11) (2024)
John Alexander, Koen Schipper, Sarah Nash, Rachel Brough, Harriet Kemp, Jacopo Iacovacci, Clare M Isacke, Rachael Natrajan, Elinor J Sawyer, Christopher J Lord, Syed Haider
Pathway-based signatures predict patient outcome, chemotherapy benefit and synthetic lethal dependencies in invasive lobular breast cancer. British journal of cancer 130 (11) (2024)
John Alexander, Koen Schipper, Sarah Nash, Rachel Brough, Harriet Kemp, Jacopo Iacovacci, Clare M Isacke, Rachael Natrajan, Elinor J Sawyer, Christopher J Lord, Syed Haider
Pathway-based signatures predict patient outcome, chemotherapy benefit and synthetic lethal dependencies in invasive lobular breast cancer. British journal of cancer (2024)
John Alexander, Koen Schipper, Sarah Nash, Rachel Brough, Harriet Kemp, Jacopo Iacovacci, Clare M Isacke, Rachael Natrajan, Elinor J Sawyer, Christopher J Lord, Syed Haider
Pathway-based signatures predict patient outcome, chemotherapy benefit and synthetic lethal dependencies in invasive lobular breast cancer. British journal of cancer 130 (11) (2024)
Arany Soosainathan, Marjan Iravani, Rania El-Botty, John Alexander, Laura Sourd, Ludivine Morisset, Pierre Painsec, Rebecca Orha, Joanna Nikitorowicz-Buniak, Sunil Pancholi, Syed Haider, Mitchell Dowsett, Elisabetta Marangoni, Lesley-Ann Martin, Clare M Isacke
Targeting transcriptional regulation with a CDK9 inhibitor suppresses growth of endocrine- and palbociclib-resistant ER+ breast cancers. Cancer research (2023)
Marta J Llorca-Cardenosa, Lauren I Aronson, Dragomir B Krastev, Jadwiga Nieminuszczy, John Alexander, Feifei Song, Malgorzata Dylewska, Ronan Broderick, Rachel Brough, Astrid Zimmermann, Frank T Zenke, Bora Gurel, Ruth Riisnaes, Ana Ferreira, Theodoros I Roumeliotis, Jyoti Sharma Choudhary, Stephen J Pettitt, Johann S de Bono, Andres Cervantes, Syed Haider, Wojciech Niedzwiedz, Christopher J Lord, Irene Y Chong
SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance. Cancer research 82 (21) (2022)
Hans Prakash Sathasivam, Ralf Kist, Philip Sloan, Peter Thomson, Michael Nugent, John Alexander, Syed Haider, Max Robinson
Predicting the clinical outcome of oral potentially malignant disorders using transcriptomic-based molecular pathology. British journal of cancer 125 (3) (2021)
Ute Jungwirth, Antoinette van Weverwijk, Rachel J Evans, Liam Jenkins, David Vicente, John Alexander, Qiong Gao, Syed Haider, Marjan Iravani, Clare M Isacke
Impairment of a distinct cancer-associated fibroblast population limits tumour growth and metastasis. Nature communications 12 (1) (2021)
Ilirjana Bajrami, Callum Walker, Dragomir B Krastev, Daniel Weekes, Feifei Song, Andrew J Wicks, John Alexander, Syed Haider, Rachel Brough, Stephen J Pettitt, Andrew N J Tutt, Christopher J Lord
Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency. Communications biology 4 (1) (2021)
Stephen J Pettitt, Jessica R Frankum, Marco Punta, Stefano Lise, John Alexander, Yi Chen, Timothy Anthony Yap, Syed Haider, Andrew N J Tutt, Christopher J Lord
Clinical BRCA1/2 Reversion Analysis Identifies Hotspot Mutations and Predicted Neoantigens Associated with Therapy Resistance. Cancer discovery 10 (10) (2020)
Oliver Thompson, Ferdinand von Meyenn, Zoe Hewitt, John Alexander, Andrew Wood, Richard Weightman, Sian Gregory, Felix Krueger, Simon Andrews, Ivana Barbaric, Paul J Gokhale, Harry D Moore, Wolf Reik, Marta Milo, Serena Nik-Zainal, Kosuke Yusa, Peter W Andrews
Low rates of mutation in clinical grade human pluripotent stem cells under different culture conditions. Nature communications 11 (1) (2020)